Literature DB >> 7856562

Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.

H F Frierson1, R A Wolber, K W Berean, D W Franquemont, M J Gaffey, J C Boyd, D C Wilbur.   

Abstract

The interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for invasive breast carcinoma was tested. Six surgical pathologists from four institutions independently evaluated histologic grade and each of its three components for 75 infiltrating ductal carcinomas. The number of slides per case ranged from one to nine (median 3). Pairwise kappa values for agreement ranged from moderate to substantial (0.43-0.74) for histologic grade. Generalized kappa values indicated substantial agreement for tubule formation (0.64), moderate agreement for mitotic count (0.52), and near moderate agreement for nuclear pleomorphism (0.40). Normalizing the mitotic counts per mm2 showed only slight improvement in agreement over the published range of mitotic counts for three different field areas. The results suggest that steps to discriminate between categories for nuclear pleomorphism would likely be of benefit for improving the interobserver reproducibility of histologic grade. Nevertheless, the Nottingham modification of the Bloom and Richardson grading system is recommended as a suitable scheme for evaluating invasive breast carcinomas in the routine clinical setting.

Entities:  

Mesh:

Year:  1995        PMID: 7856562     DOI: 10.1093/ajcp/103.2.195

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  62 in total

1.  Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.

Authors:  A G Douglas-Jones; J M Morgan; M A Appleton; R L Attanoos; A Caslin; C S Champ; M Cotter; N S Dallimore; A Dawson; R W Fortt; A P Griffiths; M Hughes; P A Kitching; C O'Brien; A M Rashid; D Stock; A Verghese; D W Williams; N W Williams; S Williams
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

Review 2.  Practical implications of gene-expression-based assays for breast oncologists.

Authors:  Aleix Prat; Matthew J Ellis; Charles M Perou
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

Review 3.  Preoperative assessment of prognostic factors in breast cancer.

Authors:  H Denley; S E Pinder; C W Elston; A H Lee; I O Ellis
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 4.  The significance of quality of life in health care.

Authors:  Robert M Kaplan
Journal:  Qual Life Res       Date:  2003       Impact factor: 4.147

5.  Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen.

Authors:  Victor Piana de Andrade; Helenice Gobbi
Journal:  Virchows Arch       Date:  2004-10-08       Impact factor: 4.064

6.  Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?

Authors:  P H Tan; B C-S Ho; S Selvarajan; W M Yap; A Hanby
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

7.  Prognostic factors affecting locoregional recurrence in patients with stage IIIB noninflammatory breast cancer.

Authors:  Kaptan Gülben; Uğur Berberoğlu; Aziz Cengiz; Hüseyin Altınyollar
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

Review 8.  An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens.

Authors:  E A Rakha; I O Ellis
Journal:  J Clin Pathol       Date:  2007-07-14       Impact factor: 3.411

9.  [Prognostic and predictive factors of invasive breast cancer: update 2009].

Authors:  T Decker; D Hungermann; W Böcker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

10.  Tumor stiffness measured by quantitative and qualitative shear wave elastography of breast cancer.

Authors:  Eun Jee Song; Yu-Mee Sohn; Mirinae Seo
Journal:  Br J Radiol       Date:  2018-04-09       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.